Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 8 | 2012 | 689 | 1.600 |
Why?
|
| Reactive Oxygen Species | 10 | 2016 | 492 | 1.370 |
Why?
|
| Glycolysis | 7 | 2018 | 147 | 1.170 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2016 | 719 | 1.050 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2016 | 183 | 1.040 |
Why?
|
| Glutathione | 6 | 2016 | 194 | 0.980 |
Why?
|
| Antineoplastic Agents | 9 | 2023 | 1674 | 0.970 |
Why?
|
| Isothiocyanates | 3 | 2016 | 13 | 0.960 |
Why?
|
| Neoplasms | 11 | 2023 | 2801 | 0.910 |
Why?
|
| Stromal Cells | 3 | 2013 | 299 | 0.770 |
Why?
|
| Pancreatic Neoplasms | 6 | 2024 | 685 | 0.640 |
Why?
|
| Oxidation-Reduction | 6 | 2014 | 445 | 0.620 |
Why?
|
| Cell Survival | 8 | 2012 | 806 | 0.570 |
Why?
|
| Organelle Biogenesis | 1 | 2016 | 16 | 0.540 |
Why?
|
| Chromosome Deletion | 2 | 2016 | 647 | 0.530 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2023 | 722 | 0.440 |
Why?
|
| Cell Communication | 2 | 2012 | 167 | 0.430 |
Why?
|
| Apoptosis | 8 | 2013 | 1789 | 0.430 |
Why?
|
| Cystine | 1 | 2012 | 15 | 0.400 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 619 | 0.390 |
Why?
|
| DNA, Mitochondrial | 4 | 2009 | 211 | 0.380 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 116 | 0.380 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 261 | 0.350 |
Why?
|
| Glutamine | 1 | 2011 | 210 | 0.340 |
Why?
|
| Lignans | 1 | 2009 | 4 | 0.330 |
Why?
|
| Energy Metabolism | 3 | 2018 | 778 | 0.320 |
Why?
|
| Pyruvates | 1 | 2009 | 21 | 0.320 |
Why?
|
| Hexokinase | 1 | 2009 | 20 | 0.320 |
Why?
|
| Biphenyl Compounds | 1 | 2009 | 56 | 0.320 |
Why?
|
| Reactive Nitrogen Species | 1 | 2008 | 8 | 0.310 |
Why?
|
| Mutation | 6 | 2016 | 5809 | 0.310 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 185 | 0.310 |
Why?
|
| Nitrosamines | 1 | 2008 | 18 | 0.300 |
Why?
|
| Carcinogens | 2 | 2008 | 153 | 0.300 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2024 | 153 | 0.300 |
Why?
|
| Cell Respiration | 3 | 2016 | 24 | 0.300 |
Why?
|
| Leukemia | 1 | 2011 | 376 | 0.300 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 52 | 0.290 |
Why?
|
| Esophagus | 1 | 2009 | 215 | 0.280 |
Why?
|
| Epithelial Cells | 2 | 2009 | 911 | 0.270 |
Why?
|
| Bile Acids and Salts | 1 | 2009 | 245 | 0.270 |
Why?
|
| Cell Line, Tumor | 10 | 2018 | 3341 | 0.270 |
Why?
|
| Chalcones | 1 | 2006 | 5 | 0.260 |
Why?
|
| Boron Compounds | 1 | 2006 | 33 | 0.260 |
Why?
|
| Proteasome Inhibitors | 1 | 2006 | 61 | 0.260 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 158 | 0.250 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2005 | 79 | 0.240 |
Why?
|
| RNA, Small Interfering | 5 | 2012 | 670 | 0.240 |
Why?
|
| Signal Transduction | 5 | 2014 | 4534 | 0.240 |
Why?
|
| Animals | 17 | 2024 | 34139 | 0.240 |
Why?
|
| DNA Damage | 2 | 2005 | 514 | 0.240 |
Why?
|
| Esophageal Neoplasms | 1 | 2009 | 359 | 0.230 |
Why?
|
| Genomic Instability | 1 | 2005 | 229 | 0.220 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2023 | 18 | 0.220 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2024 | 79 | 0.220 |
Why?
|
| Humans | 30 | 2024 | 124398 | 0.210 |
Why?
|
| Proteostasis | 1 | 2023 | 34 | 0.210 |
Why?
|
| Endoribonucleases | 1 | 2023 | 82 | 0.210 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2023 | 143 | 0.210 |
Why?
|
| Adenocarcinoma | 3 | 2014 | 998 | 0.190 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 1604 | 0.190 |
Why?
|
| Mice | 11 | 2024 | 17725 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 2 | 2012 | 107 | 0.190 |
Why?
|
| HL-60 Cells | 2 | 2011 | 32 | 0.180 |
Why?
|
| Enzyme Inhibitors | 1 | 2023 | 578 | 0.180 |
Why?
|
| Immunoblotting | 4 | 2016 | 313 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 1899 | 0.170 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 139 | 0.170 |
Why?
|
| Oncogenes | 2 | 2011 | 168 | 0.160 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 58 | 0.150 |
Why?
|
| Transfection | 3 | 2012 | 1069 | 0.150 |
Why?
|
| Neoplastic Stem Cells | 2 | 2011 | 300 | 0.150 |
Why?
|
| Flow Cytometry | 3 | 2012 | 802 | 0.150 |
Why?
|
| Boronic Acids | 3 | 2006 | 48 | 0.140 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 15 | 0.140 |
Why?
|
| Peroxiredoxins | 1 | 2016 | 9 | 0.130 |
Why?
|
| Sirtuin 2 | 1 | 2016 | 11 | 0.130 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2016 | 5 | 0.130 |
Why?
|
| Glutaminase | 1 | 2016 | 14 | 0.130 |
Why?
|
| Mice, Nude | 3 | 2013 | 710 | 0.130 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 467 | 0.120 |
Why?
|
| Enzyme Activation | 3 | 2012 | 623 | 0.120 |
Why?
|
| Cell Line | 2 | 2012 | 2770 | 0.120 |
Why?
|
| Models, Biological | 2 | 2011 | 1459 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 2 | 2005 | 219 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2016 | 370 | 0.120 |
Why?
|
| Deoxycytidine | 1 | 2014 | 76 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2018 | 753 | 0.110 |
Why?
|
| Genes, ras | 1 | 2014 | 97 | 0.110 |
Why?
|
| Cell Death | 2 | 2018 | 240 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 100 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 211 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 887 | 0.100 |
Why?
|
| NADPH Oxidase 1 | 1 | 2012 | 2 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 1064 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 162 | 0.100 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2012 | 24 | 0.100 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 29 | 0.100 |
Why?
|
| HCT116 Cells | 2 | 2016 | 55 | 0.100 |
Why?
|
| Tetracycline | 1 | 2012 | 77 | 0.100 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 80 | 0.100 |
Why?
|
| Vidarabine | 1 | 2012 | 80 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2014 | 701 | 0.100 |
Why?
|
| NADH Dehydrogenase | 1 | 2011 | 6 | 0.100 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 80 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2012 | 392 | 0.100 |
Why?
|
| Buthionine Sulfoximine | 1 | 2011 | 28 | 0.100 |
Why?
|
| Electron Transport Complex I | 1 | 2011 | 32 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 823 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2014 | 334 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2012 | 233 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2012 | 1108 | 0.090 |
Why?
|
| Cysteine | 1 | 2012 | 135 | 0.090 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 199 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 354 | 0.090 |
Why?
|
| Melanoma | 1 | 2018 | 832 | 0.090 |
Why?
|
| Plasmids | 1 | 2012 | 514 | 0.090 |
Why?
|
| Carcinoma | 1 | 2013 | 280 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 204 | 0.090 |
Why?
|
| Membrane Potentials | 1 | 2011 | 304 | 0.090 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1697 | 0.080 |
Why?
|
| Cyclophilins | 1 | 2009 | 19 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 169 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 408 | 0.080 |
Why?
|
| Pyrazines | 2 | 2005 | 73 | 0.080 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3753 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2011 | 444 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2013 | 889 | 0.080 |
Why?
|
| Ubiquitin | 2 | 2006 | 142 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2006 | 79 | 0.080 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 41 | 0.080 |
Why?
|
| Thioredoxins | 1 | 2008 | 25 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 306 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 258 | 0.070 |
Why?
|
| Bronchi | 1 | 2008 | 98 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 270 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 548 | 0.070 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2006 | 25 | 0.070 |
Why?
|
| DNA Polymerase gamma | 1 | 2005 | 10 | 0.060 |
Why?
|
| Lymphoma | 1 | 2009 | 322 | 0.060 |
Why?
|
| eIF-2 Kinase | 1 | 2005 | 36 | 0.060 |
Why?
|
| Antioxidants | 1 | 2008 | 337 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 286 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 266 | 0.060 |
Why?
|
| Disease Progression | 1 | 2011 | 2042 | 0.060 |
Why?
|
| Base Sequence | 1 | 2009 | 3093 | 0.060 |
Why?
|
| Piperidines | 1 | 2006 | 204 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 660 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2508 | 0.060 |
Why?
|
| Homeostasis | 1 | 2008 | 692 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 488 | 0.060 |
Why?
|
| Calcium | 2 | 2005 | 1095 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2024 | 100 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 247 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2024 | 141 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2014 | 238 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 1584 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2002 | 213 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1684 | 0.050 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2018 | 6 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 1240 | 0.040 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2018 | 15 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 88 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 645 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2018 | 53 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2018 | 174 | 0.040 |
Why?
|
| Comet Assay | 1 | 2016 | 11 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2016 | 43 | 0.030 |
Why?
|
| Oxidants | 1 | 2016 | 25 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2016 | 813 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2304 | 0.030 |
Why?
|
| Peroxidase | 1 | 2016 | 62 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1272 | 0.030 |
Why?
|
| Thapsigargin | 2 | 2005 | 22 | 0.030 |
Why?
|
| Caspase Inhibitors | 2 | 2005 | 31 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 2088 | 0.030 |
Why?
|
| Bortezomib | 2 | 2005 | 73 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 67 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 348 | 0.030 |
Why?
|
| Caspases | 2 | 2005 | 162 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 534 | 0.030 |
Why?
|
| Prognosis | 1 | 2024 | 4554 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 285 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 114 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 389 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 350 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 571 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2013 | 28 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 4425 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 54 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2014 | 161 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 137 | 0.030 |
Why?
|
| RNA Interference | 1 | 2014 | 503 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2013 | 70 | 0.030 |
Why?
|
| Chemokines | 1 | 2013 | 134 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3050 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2014 | 459 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 374 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 229 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2006 | 1625 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 662 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 483 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 1614 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 1017 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2824 | 0.020 |
Why?
|
| Female | 4 | 2018 | 66305 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 95 | 0.020 |
Why?
|
| NAD | 1 | 2006 | 48 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2005 | 7 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2005 | 6 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2005 | 43 | 0.020 |
Why?
|
| Caspases, Initiator | 1 | 2005 | 6 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2005 | 35 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 51 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 91 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2005 | 253 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 260 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 168 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 340 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 195 | 0.010 |
Why?
|
| Pancreas | 1 | 2005 | 217 | 0.010 |
Why?
|
| Cisplatin | 1 | 2005 | 242 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 355 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 1006 | 0.010 |
Why?
|
| Cyclin A | 1 | 2002 | 17 | 0.010 |
Why?
|
| ARNTL Transcription Factors | 1 | 2002 | 38 | 0.010 |
Why?
|
| Period Circadian Proteins | 1 | 2002 | 29 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2002 | 49 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 665 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 144 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 259 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2002 | 101 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2002 | 112 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6470 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2002 | 198 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 781 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 383 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 616 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 549 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 8979 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 1341 | 0.010 |
Why?
|
| Male | 2 | 2018 | 61025 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 1114 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 19479 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 2417 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 26459 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 4255 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 29396 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 2607 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 6272 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 3137 | 0.010 |
Why?
|